1st Quarter - Amendment

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC. for AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC

Firm
Client
Income
—
Expenses
$650,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Amendment Apr 23, 2018 $650,000 Replaced
1st Quarter - Amendment (this page) Sep 17, 2020 $650,000 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Creating parity in taxation of tobacco products respecting S. 1837; HR1 tax bill relating to its implementation roll out and impact on charitable deductions.

LobbyistCovered position, as disclosed
ROSALIE ABBOTT —
OKEYSHA BROOKS-COLEY —
GREGG HAIFLEY —
RACHEL MARCUS —
CAROLINE POWERS —

Contacted: White House Office; Centers For Disease Control & Prevention (CDC); Labor, Dept of (DOL); U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); U.S. Agency for International Development (USAID); Environmental Protection Agency (EPA); Natl Institutes of Health (NIH); Energy, Dept of; SENATE; HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA)

Bills named: H.R. 1 (115th), S. 1837 (115th)

Health Issues HCR

Issues relating to health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including: H.R.1676 & S.693, the Palliative Care and Hospice Education and Training Act; the Breast Density & Mammography Reporting Act; H.R.820 & S.292, Childhood Cancer STAR Act; and, H.R. 1231 & S. 456, the RACE for Children Act. In addition, the discussion draft of The Diagnostic Accuracy and Innovation Act; and H.R.772 and S.261, the Common Sense Nutrition Disclosure Act. Preservation of the Prevention and Public Health Fund and reauthorization of the CHIP program and FQHCs respecting H.R. 3922. Issues relating to anti-cancer medication cost-sharing parity respecting H.R. 1409. Issues regarding a national family caregiving strategy respecting S. 1719 and H.R. 1028. Issues regarding access to medicines respecting S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, as well as H.R.878, the Right to Try Act of 2017. Issues regarding lymphedema treatment respecting The Lymphedema Treatment Act, H.R. 930 and S. 497. Issues regarding access to care respecting the Bi-partisan Health Care Stabilization Act (Alexander-Murray) and S 1835, The Lower Premiums through Reinsurance Act.

LobbyistCovered position, as disclosed
ROSALIE ABBOTT —
OKEYSHA BROOKS-COLEY —
GREGG HAIFLEY —
GRETA JOHNSON —
RACHEL MARCUS —
EMILY MYATT —
MATTHEW PHELAN —
CAROLINE POWERS —

Contacted: Veterans Affairs, Dept of (VA); U.S. Trade Representative (USTR); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; White House Office; Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); U.S. Agency for International Development (USAID); SENATE; Labor, Dept of (DOL); Energy, Dept of; Environmental Protection Agency (EPA); Health Resources & Services Administration (HRSA)

Bills named: S. 497 (115th), S. 204 (115th), H.R. 1409 (115th), H.R. 878 (115th), H.R. 1676 (115th), H.R. 930 (115th), S. 261 (115th), H.R. 772 (115th), S. 292 (115th), H.R. 1028 (115th), H.R. 1231 (115th), S. 456 (115th), H.R. 820 (115th), H.R. 3922 (115th), S. 1719 (115th), S. 693 (115th)

Medicare/Medicaid MMM

Issues relating to legislative and regulatory changes to the Affordable Care Act, including H.R. 1628, the Better Care Reconciliation Act, and the Graham-Cassidy-Heller, Johnson repeal. Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1017 & S.479, 479; issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.

LobbyistCovered position, as disclosed
ROSALIE ABBOTT —
OKEYSHA BROOKS-COLEY —
GREGG HAIFLEY —
RACHEL MARCUS —
EMILY MYATT —
CAROLINE POWERS —

Contacted: Environmental Protection Agency (EPA); Labor, Dept of (DOL); Centers For Medicare and Medicaid Services (CMS); White House Office; SENATE; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); U.S. Agency for International Development (USAID); Energy, Dept of; Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); Natl Institutes of Health (NIH)

Bills named: S. 479 (115th), H.R. 1628 (115th), H.R. 1017 (115th)

Budget/Appropriations BUD

Federal budget and appropriations for cancer research and programs, including: FY 2018 federal appropriations for NIH, NCI, CDC, FDA; the Prevention & Public Health Fund, including the Labor-HHS-Education Appropriations Act and the Agriculture-FDA Appropriations Act; issues relating to non-communicable diseases with respect to the FY18 State/Foreign Operations Appropriations Act; issues related to medical isotopes with respect to the Energy and Water Development Appropriations Act; and issues relating to veterans cancer screenings with respect to the Military Construction and Veterans Affairs Appropriations Act.

LobbyistCovered position, as disclosed
ROSALIE ABBOTT —
OKEYSHA BROOKS-COLEY —
GREGG HAIFLEY —
GRETA JOHNSON —
RACHEL MARCUS —
EMILY MYATT —
CAROLINE POWERS —

Contacted: White House Office; Labor, Dept of (DOL); Health & Human Services, Dept of (HHS); U.S. Agency for International Development (USAID); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); SENATE; Health Resources & Services Administration (HRSA); Environmental Protection Agency (EPA); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Energy, Dept of; U.S. Trade Representative (USTR)

Tobacco TOB

Issues relating to smoking cessation, tobacco sales to minors, tobacco taxes, minimum smoking age, graphic warning labels, product regulation, and smoke-free environments, including: implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the proposed FDA deeming regulations. Issues relating to proposed FDA regulation of electronic cigarettes and/or cigars; H.R.564 & S.294, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act; H.R. 1136, FDA Deeming Authorization Clarification Act. Issues related to FDA tobacco control, as considered in House and Senate, FY18 Agriculture Appropriations legislation and Labor, Health and Human Services Appropriations legislation. Issues related to making Veterans Health Administration facilities smoke-free respecting H.R. 1662, H.R. 1848, and S. 2119. Issues regarding parity in taxation of tobacco products respecting S. 1837. Issues regarding raising the age for legal sale of tobacco products respecting S. 2100 and H.R, 4273.

LobbyistCovered position, as disclosed
ROSALIE ABBOTT —
OKEYSHA BROOKS-COLEY —
GREGG HAIFLEY —
RACHEL MARCUS —
CAROLINE POWERS —

Contacted: Veterans Affairs, Dept of (VA); SENATE; Natl Institutes of Health (NIH); U.S. Trade Representative (USTR); Environmental Protection Agency (EPA); Labor, Dept of (DOL); Health & Human Services, Dept of (HHS); White House Office; Energy, Dept of; Centers For Medicare and Medicaid Services (CMS); U.S. Agency for International Development (USAID); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA)

Bills named: H.R. 1662 (115th), S. 2100 (115th), H.R. 1136 (115th), S. 1837 (115th), H.R. 1848 (115th), S. 294 (115th), S. 2119 (115th), H.R. 564 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.